ArticleBMC cancer2025

Genomically determined subtypes and clinicopathological features as predictors of the efficacy of preoperative chemotherapy combined with HER2-targeted therapy for early-stage HER2-positive breast cancer.

Sayumi Imamura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.